ML23284A334
| ML23284A334 | |
| Person / Time | |
|---|---|
| Site: | 03037572 |
| Issue date: | 09/19/2023 |
| From: | Tindle-Engelmann E NRC/RGN-III/DRSS |
| To: | Kritzman M Capital Cardiology, PC |
| References | |
| IR 2023001 | |
| Download: ML23284A334 (1) | |
See also: IR 07200202/2030001
Text
(04-2022)
Materials Inspection Report
U.S. NUCLEAR REGULATORY COMMISSION
Page 1 of 1
Add Continuation Page
1. Licensee/Location Inspected:
Capital Cardiology, P.C.
1200 E Michigan Ave.
Lansing, MI
Report Number(s) 2023001
2. NRC/Regional Office
Select location (Use keyboard arrows to select) . .
3. Docket Number(s)
03037572
4. License Number(s)
21-32677-01
5. Date(s) of Inspection
September 19, 2023
LICENSEE:
The inspection was an examination of the activities conducted under your license as they relate to radiation safety and to compliance with the
Nuclear Regulatory Commission (NRC) rules and regulations and the conditions of your license. The inspection consisted of selective
examinations of procedures and representative records, interviews with personnel, and observations by the inspector. The inspection findings
are as follows:
1. Based on the inspection findings, no violations were identified.
2. Previous violation(s) closed.
3. During this inspection, certain of your activities, as described below and/or attached, were in violation of NRC requirements, and
were assessed at Severity Level IV, in accordance with the NRC Enforcement Policy.
B. The following violation(s) is/are being cited in accordance with NRC Enforcement Policy. This form is a NOTICE OF VIOLATION,
which may be subject to posting in accordance with 10 CFR 19.11.
(Violations and Corrective Actions)
Statement of Corrective Actions
I hereby state that, within 30 days, the actions described by me to the Inspector will be taken to correct the violations identified. This statement of corrective
actions is made in accordance with the requirements of 10 CFR 2.201 (corrective steps already taken, corrective steps which will be taken, date when full
compliance will be achieved). I understand that no further written response to NRC will be required, unless specifically requested.
A. The violation(s), specifically described to you by the inspector as non-cited violations, are not being cited because they were self-
identified, non-repetitive, corrective action was or is being taken, and the remaining criteria in the NRC Enforcement Policy
were satisfied.
(Non-cited violation(s) was/were discussed involving the following requirement(s)
TITLE
NRC INSPECTOR
PRINTED NAME
SIGNATURE AND DATE
LICENSEE'S
REPRESENTATIVE
Elizabeth Tindle-Engelmann
BRANCH CHIEF
Elizabeth D. Tindle-Engelmann
Digitally signed by Elizabeth D. Tindle-Engelmann
Date: 2023.09.25 10:42:53 -05'00'
Digitally signed by Rhex A. Edwards
Date: 2023.10.09 08:41:59 -05'00'
(10-04-2022)
U.S. NUCLEAR REGULATORY COMMISSION
Materials Inspection Record
Page 1 of 1
NRC Form 592M (10-04-2022)
1. Licensee Name:
Capital Cardiology, P.C.
2. Docket Number(s):
03037572
3. License Number(s)
21-32677-01
4. Report Number(s):
2023001
5. Date(s) of Inspection:
September 19, 2023
6. Inspector(s):
Elizabeth Tindle-Engelmann
7. Program Code(s):
02201
8. Priority:
5
9. Inspection Guidance Used:
87130
10. Licensee Contact Name(s):
Michelle Kritzman, RSO
11. Licensee E-mail Address:
mkritzman@mpcphysics.com
12. Licensee Telephone Number(s):
734-662-3197
13. Inspection Type:
Initial
Routine
Announced
Non-Routine
Unannounced
14. Locations Inspected:
Hybrid
Main Office
Field Office
Temporary Job Site
Remote
15. Next Inspection Date (MM/DD/YYYY):
09/19/2028
Normal
Reduced
Extended
No change
16. Location(s) Inspected List:
1200 E Michigan Ave., Lansing, MI
17. Scope and Observations:
The licensee was a medical facility with authorization for diagnostic uses of byproduct material pursuant to 10 CFR
35.200. The licensee utilized an external consultant to serve as the radiation safety officer and perform program
oversight. The licensee had one full-time nuclear medicine technologist. The licensee administered approximately 10
SPECT doses per day. The department received unit doses of primarily technetium-99m from a licensed
radiopharmacy.
The inspector observed dose preparation and administration and package receipt. The licensees staff demonstrated
decay in storage procedures and spill response. Interviews with licensee personnel indicated adequate knowledge of
radiation safety and security concepts and procedures. The inspector reviewed the following records: area surveys,
dose calibrator calibrations, dosimetry, package receipt, package return, program reviews, sealed source inventory
and leak tests, spill reports, training, and waste logs.
Independent surveys were performed using a RadEye G (SN: 30653; calibration due: 5/9/2024). Results were
consistent with the licensees survey records and postings.
No violations were identified as a result of this inspection.
Signature and Date - Branch Chief
Digitally signed by Rhex A. Edwards
Date: 2023.10.09 08:41:41 -05'00'